1. Barlow DH. Anxiety and its disorders: The nature and treatment of anxiety and panic. Wyd. 2, New York: Guilford Press. Nowy Jork 2002.
2.
Beidel DC, Turner SM, Sallee FR, Ammerman RT, Crosby LA, Pathak S. SET-C versus fluoxetine in the treatment of childhood social phobia. J Am Acad Child Adolesc Psychiatry 2007; 46(12): 1622-32.
3.
Coric V, Feldman HH, Oren DA, et al. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1.
4.
Cwojdzińska A, Rybakowski F. Operationalization of Jaak Panksepp’s concept of brain emotional systems – Affective Neuroscience Personality Scales. Neuropsychiatria i Neuropsychologia 2015; 10(3), 102-9.
5.
Davis KL, Montag C. Selected Principles of Pankseppian Affective Neuroscience. Front Neurosci 2019; 12: 1025.
6.
Ekman P. Approaches To Emotion. Wyd. 1, Psychology Press, Nowy Jork 1984.
7.
Fanselow MS, Poulos AM. The neuroscience of mammalian associative learning. Annu Rev Psychol 2005; 56: 207-34.
8.
Frampton JE. Pregabalin: a review of its use in adults with generalized anxiety disorder. CNS Drugs 2014; 28(9): 835-54.
9.
Godlewska BR, Harmer CJ. Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment. Psychopharmacology 2021; 238(5): 1265-78.
10.
Goodwin GM, Price J, De Bodinat C, Laredo J. Emotional blunting with antidepressant treatments: A survey among depressed patients. J Affect Disord 2017; 221: 31-35.
11.
Gray JA. The neuropsychology of anxiety. Issues Ment Health Nurs 1985; 7(1-4): 201-28.
12.
Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR. The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 2002; 17(1): 317-23.
13.
Hauger RL, Olivares-Reyes JA, Dautzenberg FM, Lohr JB, Braun S, Oakley RH. Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy. Neuropharmacology 2012; 62(2): 705-14.
14.
Lang PJ, Davis M. Emotion, motivation, and the brain: reflex foundations in animal and human research. Prog Brain Res 2006; 156: 3-29.
15.
Langley C, Armand S, Luo Q, et al. Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study. Neuropsychopharmacology 2023; 48(4): 664-70.
16.
LeDoux JE. The emotional brain: The mysterious underpinnings of emotional life. Simon & Schuster. Chicago 1996.
17.
LeDoux JE, Pine DS. Using Neuroscience to Help Understand Fear and Anxiety: A Two-System Framework. Am J Psychiatry 2016; 173 (11): 1083-93.
18.
Luo Q, Holroyd T, Majestic C, Cheng X, Schechter J, Blair RJ. Emotional automaticity is a matter of timing. J Neurosci 2010; 30(17): 5825-9.
19.
Nelson EE, Panksepp J. Brain substrates of infant-mother attachment: contributions of opioids, oxytocin, and norepinephrine. Neurosci Biobehav Rev 1998; 22(3): 437-52.
20.
Panksepp J. Primary process affects and brain oxytocin. Biol Psychiatry 2009; 65(9): 725-7.
21.
Panksepp J. The basic emotional circuits of mammalian brains: do animals have affective lives?. Neurosci Biobehav Rev 2011; 35(9): 1791-804.
22.
Panksepp J. Affective preclinical modeling of psychiatric disorders: taking imbalanced primal emotional feelings of animals seriously in our search for novel antidepressants. Dialogues Clin Neurosci 2015; 17(4): 363-79.
23.
Panksepp J. The Psycho-Neurology of Cross-Species Affective/Social Neuroscience: Understanding Animal Affective States as a Guide to Development of Novel Psychiatric Treatments. Curr Top Behav Neurosci 2017; 30: 109-25.
24.
Panksepp J, Fuchs T, Iacobucci P. The basic neuroscience of emotional experiences in mammals: The case of subcortical FEAR circuitry and implications for clinical anxiety. Applied Animal Behaviour Science 2011; 129(1): 1-17.
25.
Panksepp J, Herman BH, Vilberg T, Bishop P, DeEskinazi FG. Endogenous opioids and social behavior. Neurosci Biobehav Rev 1980; 4(4): 473-87.
26.
Panksepp J, Siviy S, Normansell L. The psychobiology of play: theoretical and methodological perspectives. Neurosci Biobehav Rev 1984; 8(4): 465-92.
27.
Seligman MEP. Positive psychology: Fundamental assumptions. The Psychologist 2003; 16, 126-7.
28.
Stahl SM. Podstawy psychofarmakologii. Teoria i praktyka. Tom 2. ViaMedica, Gdańsk 2009.
29.
Strawn JR, Sakolsky DJ, Rynn MA. Psychopharmacologic treatment of children and adolescents with anxiety disorders. Child Adolesc Psychiatr Clin N Am 2012; 21(3): 527-39.
30.
Vuilleumier P, Pourtois G. Distributed and interactive brain mechanisms during emotion face perception: evidence from functional neuroimaging. Neuropsychologia 2007; 45(1): 174-94.
31.
Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety [published correction appears in N Engl J Med 2013; 31; 368(5): 490.
32.
Whalen PJ, Kagan J, Cook RG, et al. Human amygdala responsivity to masked fearful eye whites. Science 2004; 306(5704): 2061.
33.
Wiggins JL, Bedoyan JK, Carrasco M, Swartz JR, Martin DM, Monk CS. Age-related effect of serotonin transporter genotype on amygdala and prefrontal cortex function in adolescence. Hum Brain Mapp 2014; 35(2): 646-58.
34.
Young SN, Moskowitz DS, Rot M. Possible role of more positive social behaviour in the clinical effect of antidepressant drugs. J Psychiatry Neurosci 2014; 39(1): 60-5.
35.
Yovell Y. Anxiety – one or two? International Neuropsychoanalysis Congress „Neuropsychoanalysis: Who needs it?”. Paryż, 27–28.06.2009.
36.
Zezula J, Cortés R, Probst A, Palacios JM. Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience 1988; 25(3): 771-95.
37.
Żechowski C. Theory of drives and emotions – from Sigmund Freud to Jaak Panksepp. Teoria emocji i popędów – od Sigmunda Freuda do Jaaka Pankseppa. Psychiatr Pol 2017; 51(6): 1181-9.
